case of distal type I endoleak and device migration (>10 mm) of a right iliac leg component was noted during longer-term follow-up. No other limb-related endoleak, migration, component separation, or stent fracture was reported during a mean follow-up of 10.8 6 5.6 months.
PC028. The Effect of Rigid Stent Grafts on the Propagation of Pressures in Aortic Dissection
Objectives: Aortic dissections, which affect 12,000 new patients per year in the United States, are associated with significant morbidity and mortality. The etiology is unclear, but the underlying pathophysiology may be related to hypertension-induced injury in the setting of an aorta that has lost compliance. Aortic stent grafts can effectively treat acute complications of aortic dissection. Stent grafts are essentially rigid tubes, and after implantation, pressure with systole has to be dissipated by the residual aorta proximal and distal to the stent graft. Our group postulated that the rigid stent itself may exacerbate pressure on the residual aorta. These regions of native aorta proximal to the stent graft are required to limit pressure differences, inducing larger stresses and increasing the potential of aortic tearing. Stent graft-induced new tears (SINE) have been recorded in 30% of patients treated with a stent graft for aortic dissection, and retrograde type A dissection has been seen in 4%. We hypothesized that the rigidity of the stent graft could be responsible for these complications. We developed a mathematical lumped parameter model to evaluate this.
Methods: The main objective of this work was to investigate whether one fundamental cause of SINE dissections is an increase in internal blood pressure with the incorporation of a rigid stent graft into the native aorta by using a lumped-parameter model. The interaction between the blood pressure wave and the aortic wall was the major consideration. The aorta was modeled as a compliant tube with variable compliance between the native tissue and the stent graft.
Results: A lumped-parameter model predicted an increase in peak pressure for patients with a rigid stent graft (Fig 1) . The lumped-parameter model predicted an increase in peak pressure for patients with a longer rigid stent graft and compared to patients with a shorter rigid stent graft (Fig 2) .
Conclusions:
The model showed an increase in peak pressure after stent graft implantation in the proximal native aorta. This is exacerbated with increased graft length. Further investigation, using a computational finite-element model, is in progress to determine how much local pressure rise is significant and whether larger pressure shifts would occur given the complexity of aortic blood flow. Objectives: The objective of this study is to determine the rate of overall long-term sac regression following endovascular aneurysm repair (EVAR) and the influence of specific endograft devices used at our center.
Methods: This retrospective cohort study included all EVARs performed for intact and ruptured abdominal aortic aneurysms (AAAs) at a tertiary care, university teaching hospital. Preoperative, operative, and follow-up data were collected using a regional registry and institutional databases. Preoperative and post-EVAR sac diameters were determined by a blinded observer in accordance with Society for Vascular Surgery guidelines. Absolute and relative sac regression was determined at the intervals of 0 to 6 months, 6 to 12 months, 12 to 18 months, 18 months to 2 years, 2 to 5 years, 5 to 10 years, and >10 years.
Results: From 1999 to 2015, 1060 patients underwent EVAR for an AAA at the Ottawa Hospital, using nine unique endograft devices, with five devices (Cook Zenith, n ¼ 398; Medtronic Endurant, n ¼ 375; Medtronic Talent, n ¼ 183; Cook Zenith LP, n ¼ 52; and Terumo Anaconda, n ¼ 23) used in 97% of procedures. The mean preoperative AAA diameter was 61.2 mm, with no detectable differences between endograft devices with respect to age, preoperative AAA diameter, or rupture diagnosis. Overall mean sac regression went from e1.3 mm at 6 months to e14.9 mm >10 years. The majority of sac regression (88.7%) was achieved within 2 years. Only 90 of 1060 patients (8.5%) experienced sac expansion >5 mm at some point during their follow-up period. Kaplan-Meier analysis revealed that Zenith, Zenith LP, and Endurant endografts demonstrated the shortest time to >5 mm sac regression among devices used in >10 patients (Fig 1) . In patients who never had a type I endoleak in follow-up, the Zenith endograft demonstrated the most statistically significant sac regression at all intervals (Fig 2) . Cox proportional hazard modeling demonstrated that age <75 years (hazard ratio [HR], 1.4; P ¼ .001), female gender (HR, 1.4; P ¼ .003), absence of type I endoleak (HR, 4.6; P < .0001), AAA >70 mm (HR, 3.7; P < .0001) and that the Zenith (HR, 2.0; P < .0001) and Endurant (HR, 1.7; P ¼ .001) devices were both associated with shorter time to >5 mm sac regression.
Conclusions: This study demonstrated a pattern of sac diameter change following EVAR, with the majority of sac regression occurring within the first 2 years. Variability in sac regression was most influenced by age, gender, original AAA diameter, absence of endoleak, and endograft device. The relationship between specific endograft design and material, and sac regression is yet to be determined.
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PC032.
Planned Perioperative Adjunctive Maneuvers Make Off-Label Endovascular Aneurysm Repair (EVAR) Comparable to Standard EVAR at a Long-Term Follow-Up Emiliano Chisci, Azzurra Guidotti, Clara Pigozzi, Eugenio Romano, Pierfrancesco Frosini, Nicola Troisi, Leonardo Ercolini, Stefano Michelagnoli. San Giovanni di Dio Hospital, Florence, Italy
Objectives: Literature has shown that a considerable percentage of endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) has been performed outside the instructions for use (IFU). However, off-label EVAR durability and long-term patients' safety are still under investigations. We report long-term outcomes after EVAR with respect to a procedure performed according or not to the devices IFU.
Methods Sac regression in patients who had no evidence of any type I endoleak at any point during their follow-up. Statistically significant differences using analysis of variance and Tukey adjustment for multiple comparisons were detected for sac regression by endograft device in the setting of no type I endoleak (Zenith vs Talent endografts at 12 months, P < .012; at 18 months, P ¼ .004; 2 years, P < .0001, P ¼ .0007; 5 years, P ¼ .0004). A further difference was detected between Zenith and Endurant endografts at 5 years, P ¼ .0007. The dashed lines represent endografts placed in <10 patients and thus not included in statistical comparisons.
